Tianqin Li
ABSTRACT
Lung cancer is the deadliest cancer in the word, leading to over a quarter of death in the United States in 2017. Gaining precise information on cancer prognosis for patients would greatly benefit their decision making for further treatment plans. While previous studies tend to use histology information and genomic signatures for cancer prognosis, this study explores the possibility of using expression level alone to predict prognosis. Using over 200 patients from publicly available datasets with overall survival length and transcriptomic information, we use support vector machines to predict prognosis. Our result proves the effectiveness of such methodology, encouraging transcriptomic data to be collected for patients routinely if possible given the decreasing cost of RNA-Seq.
- Rebecca Siegel, Kimberly D. Miller, Stacey A. Fedewa, Dennis J. Ahnen, Reinier GS Meester, Afsaneh Barzi, and Ahmedin Jemal. "Colorectal cancer statistics, 2017." CA: a Cancer Journal for Clinicians 67, no. 3 (2017): 177--193.Google Scholar
Cross Ref
- Marc Ladanyi and William Pao. "Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond." Modern pathology 21, no. S2 (2008): S16.Google Scholar
- Song Cao and Ram Nevatia. "Exploring deep learning based solutions in fine grained activity recognition in the wild." In Pattern Recognition (ICPR), 2016. 23rd International Conference on, pp. 384--389. IEEE, 2016.Google Scholar
- Genquan Duan, Haizhou Ai, Junliang Xing, Song Cao, and Shihong Lao. "Scene aware detection and block assignment tracking in crowded scenes." Image and Vision Computing 30, no. 4--5 (2012): 292--305. Google ScholarDigital Library
- Joseph A. Cruz and David S. Wishart. "Applications of machine learning in cancer prediction and prognosis." Cancer Informatics 2 (2006): 117693510600200030.Google ScholarCross Ref
- Konstantina Kourou, Themis P. Exarchos, Konstantinos P. Exarchos, Michalis V. Karamouzis, and Dimitrios I. Fotiadis. "Machine learning applications in cancer prognosis and prediction." Computational and Structural Biotechnology Journal. 13 (2015): 8--17.Google ScholarCross Ref
- Cancer Genome Atlas Research Network. "Comprehensive genomic characterization of squamous cell lung cancers." Nature. 489, no. 7417 (2012): 519.Google ScholarCross Ref
- Cancer Genome Atlas Research Network. "Comprehensive molecular profiling of lung adenocarcinoma." Nature. 511, no. 7511 (2014): 543.Google ScholarCross Ref
- Melissa S. Cline, Brian Craft, Teresa Swatloski, Mary Goldman, Singer Ma, David Haussler and Jingchun Zhu. "Exploring TCGA pan-cancer data at the UCSC cancer genomics browser." Scientific Reports 3 (2013): 2652.Google ScholarCross Ref
- Chuan Li, Wenfeng Qian, Calum J. Maclean, and Jianzhi Zhang. "The fitness landscape of a tRNA gene." Science 352, no. 6287 (2016): 837--840.Google ScholarCross Ref
- Thomas, D. "Clinical application of tumour dna sequencing & tumour gene expression profiling in advanced metastatic breast cancer: A review of 36 patients tested between 2011 and 2017." European Journal of Cancer. 92 (2018): S111.Google ScholarCross Ref
- Jay Shendure, Shankar Balasubramanian, George M. Church, Walter Gilbert, Jane Rogers, Jeffery A. Schloss and Robert H. Waterston. "DNA sequencing at 40: past, present and future." Nature. 550, no. 7676 (2017): 345.Google ScholarCross Ref
- Chuan Li and Jianzhi Zhang. "Multi-environment fitness landscapes of a tRNA gene." Nature Ecology & Evolution 2, no. 6 (2018): 1025.Google ScholarCross Ref
- Katarzyna Tomczak, Patrycja Czerwinska, and Maciej Wiznerowicz. "The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge." Contemporary Oncology 19, no. 1A (2015): A68.Google Scholar
Index Terms
- Using the SVM Method for Lung Adenocarcinoma Prognosis Based on Expression Level
Recommendations
Applying Machine Learning to Facilitate Personalized Medicine in Lung Adenocarcinoma
ICCDA '19: Proceedings of the 2019 3rd International Conference on Compute and Data AnalysisLung adenocarcinoma (LUAD) is the leading cause of death by cancer in the United States in 2017. Multiple therapies have been developed and approved by FDA for curing LUAD. However, various patients respond quite differently to the same treatment ...
Using Multiple Machine Learning Algorithms for Cancer Prognosis in Lung Adenocarcinoma
ICBBB '20: Proceedings of the 2020 10th International Conference on Bioscience, Biochemistry and BioinformaticsLung cancer is the most prevailing source of death due to cancer, accounting for over 25% of death in the United States. Being able to predict the survival time for patients will provide valuable information for the choice of their treatment plans and ...
Applying Machine Learning in Cancer Prognosis Using Expression Profiles of Candidate Genes
ICBEB 2018: Proceedings of the 2nd International Conference on Biomedical Engineering and BioinformaticsCancer progression is a dynamic process that involves a wide spectrum of changes in expression levels for multiple genes. Increasing amount of data has been collected for patients, such as genome, transcriptome, prognosis, and histology images of the ...
Comments